Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-05-18 4:43 pm Purchase |
2021-05-18 | 13D | TELA Bio, Inc. TELA |
EW HEALTHCARE PARTNERS FUND 2 L.P. | 1,678,713 11.620% |
203,420 (+13.79%) |
Filing History |
| 2021-02-18 5:13 pm Purchase |
2020-12-31 | 13D | TELA Bio, Inc. TELA |
EW HEALTHCARE PARTNERS FUND 2 L.P. | 1,475,293 10.220% |
706,062 (+91.79%) |
Filing History |
| 2021-02-12 09:46 am Purchase |
2020-12-31 | 13G | TELA Bio, Inc. TELA |
RTW Investments, LP | 1,383,816 9.590% |
244,458 (+21.46%) |
Filing History |
| 2021-01-26 2:25 pm Unchanged |
2020-12-31 | 13G | TELA Bio, Inc. TELA |
Quaker BioVentures II LP | 1,769,196 12.200% |
0 (Unchanged) |
Filing History |
| 2020-07-15 5:01 pm Purchase |
2019-12-31 | 13G | TELA Bio, Inc. TELA |
SIGNET HEALTHCARE PARTNERS QP PARTNERSHIP III LP | 618,609 5.420% |
618,609 (New Position) |
Filing History |
| 2020-07-01 5:31 pm Unchanged |
2020-06-30 | 13D | TELA Bio, Inc. TELA |
ORBIMED ADVISORS LLC | 3,058,267 21.200% |
0 (Unchanged) |
Filing History |